Varex Imaging Corporation reported fourth quarter fiscal year 2025 revenues of $229.0 million, an 11% increase year-over-year. Medical segment revenue was $152.0 million, up 5%, while Industrial segment revenue was $77.0 million, up 25%. For the full fiscal year 2025, revenues reached $845.0 million, a 4% increase over the prior year. The company reported a GAAP net loss of $1.70 per diluted share for the year, while non-GAAP net income was $0.90 per diluted share. Cash flow from operations totaled $42.0 million for fiscal 2025. Varex highlighted growth in global CT tube sales in the Medical segment and sustained momentum in its Industrial segment, including over $55.0 million in cargo systems orders and shipment of more than 15 new systems. The company also advanced photon counting technology for CT and launched a new radiographic detector from its facility in India.